Market Size of Infection Surveillance Solutions Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 0.63 Billion |
Market Size (2029) | USD 1.20 Billion |
CAGR (2024 - 2029) | 13.87 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Infection Surveillance Solutions Market Analysis
The Infection Surveillance Solutions Market size is estimated at USD 0.63 billion in 2024, and is expected to reach USD 1.20 billion by 2029, growing at a CAGR of 13.87% during the forecast period (2024-2029).
- Stringent government policies for preventing hospital-associated infections are aiding in developing analytical and infection surveillance solutions for application in the healthcare industry. Hospital-acquired infections are a major cause of mortality and morbidity and provide a challenge to clinicians.
- The US Department of Health and Human Services released the 'National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination (HAI Action Plan),' outlining specific five-year goals for the prevention of healthcare-associated infections. Additionally, the World Health Organization (WHO) developed a protocol for implementing the Surgical Unit-based Safety Programme in African hospitals.
- Moreover, the rise in the number of surgeries is also one of the drivers of the market, as with surgery, surgical site infections (SSIs) represent a substantial clinical and economic burden on patients and the healthcare system. The prevention of SSIs entails surveillance activities. According to the Lancet Commission for Global Surgery (LCoGS), 11% of the global burden of the disease requires surgical care, anesthesia management, or both. Some studies have estimated this burden to be as high as 30%. The LCoGS estimated that 5,000 surgeries are required to meet the surgical burden of disease for 100,000 people in LMICs (low-to-middle-income countries).
- Surgical site infections are not just a problem for poor countries; in the United States, they contribute to patients spending more than 400,000 extra days in hospital at the cost of an additional USD 10 billion per year (source: WHO).
- However, Healthcare providers are often reluctant to engage with technology, partly due to the scale and pace of changes and partly through lack of education and training and concerns over liability and funding.
- Moreover, many healthcare facilities are required by regulatory bodies to have infection surveillance solutions in place. For instance, the International Health Regulations (2005) (IHR 2005) require countries to designate a National IHR Focal Point for communications with WHO to establish and maintain core capacities for surveillance and response, including at designated points of entry.
Infection Surveillance Solutions Industry Segmentation
The demand for infection surveillance has been on the rise as the need to curb hospital-acquired infections and other epidemics is intensifying. Infection surveillance solutions are designed to continuously monitor and interpret health data to ensure accurate implementation of preventive measures. The major factors contributing to the growth of this market include an increase in the incidence of HAIs and a growth in the number of surgeries coupled with government protocols for the prevention of HAIs.
The infection surveillance solutions market is segmented by offering (software and services), end-user (hospitals, long-term care facilities, and other end-users), and geography (Europe, Asia-Pacific, and the Rest of the World). The report offers market forecasts and size in value (USD) for all the above segments.
By Offering | |||||
| |||||
|
By End-User | |
Hospitals | |
Long-term Care Facilities | |
Other End Users |
By Geography*** | |||||||
| |||||||
| |||||||
| |||||||
Australia and New Zealand | |||||||
Latin America | |||||||
Middle East and Africa |
Infection Surveillance Solutions Market Size Summary
The Infection Surveillance Solutions Market is poised for significant growth, driven by stringent government policies aimed at preventing hospital-associated infections and the increasing number of surgeries worldwide. These factors have led to a heightened demand for analytical and surveillance solutions within the healthcare sector. The market is further bolstered by initiatives from organizations such as the US Department of Health and Human Services and the World Health Organization, which have set forth plans and protocols to reduce healthcare-associated infections. Despite the challenges healthcare providers face in adopting new technologies, regulatory requirements and the need for effective infection control measures are propelling the market forward. The importance of maintenance and support services, particularly in post-surgical settings, underscores the critical role of surveillance solutions in mitigating infections and improving patient outcomes.
North America stands out as a major player in the Infection Surveillance Solutions Market, with the United States leading due to its robust research and development activities in medical sciences. Government initiatives and the high incidence of healthcare-associated infections are key drivers in this region. The market is characterized by intense competition among global players, who are focusing on product innovation, strategic partnerships, and acquisitions to maintain their competitive edge. Recent advancements, such as GAMA Healthcare's infection prevention solutions and Wolters Kluwer's Sentri Sepsis Monitor, highlight the ongoing efforts to enhance infection surveillance capabilities. Additionally, international collaborations, like the one between GSK plc and Microsoft in Nepal, demonstrate the global commitment to leveraging technology in combating infectious diseases. These dynamics are shaping the market landscape, fostering growth and technological advancements in infection surveillance solutions.
Infection Surveillance Solutions Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Stringent Government Policies for Preventing Hospital Associated Infections
-
1.2.2 Rise in the Number of Surgeries
-
-
1.3 Market Restraints
-
1.3.1 Reluctance Among Medical Professionals to Adopt Advanced Healthcare Tools
-
-
1.4 Industry Value Chain Analysis
-
1.5 Industry Attractiveness - Porter's Five Forces Analysis
-
1.5.1 Threat of New Entrants
-
1.5.2 Bargaining Power of Buyers/Consumers
-
1.5.3 Bargaining Power of Suppliers
-
1.5.4 Threat of Substitute Products
-
1.5.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Offering
-
2.1.1 Software
-
2.1.1.1 On-Premise
-
2.1.1.2 Cloud
-
-
2.1.2 Services
-
2.1.2.1 Maintenance and Support
-
2.1.2.2 Consultation and Training
-
2.1.2.3 Implementation Service
-
-
-
2.2 By End-User
-
2.2.1 Hospitals
-
2.2.2 Long-term Care Facilities
-
2.2.3 Other End Users
-
-
2.3 By Geography***
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
-
2.3.2 Europe
-
2.3.2.1 United Kingdom
-
2.3.2.2 Germany
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
-
2.3.3 Asia
-
2.3.3.1 China
-
2.3.3.2 India
-
2.3.3.3 Japan
-
-
2.3.4 Australia and New Zealand
-
2.3.5 Latin America
-
2.3.6 Middle East and Africa
-
-
Infection Surveillance Solutions Market Size FAQs
How big is the Infection Surveillance Solutions Market?
The Infection Surveillance Solutions Market size is expected to reach USD 0.63 billion in 2024 and grow at a CAGR of 13.87% to reach USD 1.20 billion by 2029.
What is the current Infection Surveillance Solutions Market size?
In 2024, the Infection Surveillance Solutions Market size is expected to reach USD 0.63 billion.